 NEW YORK, Feb. 8, 2021 PRNewswire -- Scopus BioPharma Inc. Nasdaq: SCPS today announced that the underwriters of the companys follow-on public offering exercised their over-allotment option in full, bringing total proceeds to 10.35 million. The exercise of the over-allotment option... 